NRG-GY026, "A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma," (#NCT05256225)

Is this Study for You?

Let's Get Started!



Type of Study



Cherry Creek Medical Center
Highlands Ranch Hospital
University of Colorado Hospital

Principal Investigator
Photograph of Marisa Moroney,  MD

Marisa Moroney, MD

Study ID

Protocol Number: 22-1764

More information available at NCT05256225

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers